MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLUMIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLUMIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU

MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪54.95 B‬KRW
Fund flows (1Y)
‪−84.53 B‬KRW
Dividend yield (indicated)
1.74%
Discount/Premium to NAV
Shares outstanding
‪6.37 M‬
Expense ratio
0.45%

About MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Tiger ETF
Home page
Inception date
Feb 29, 2024
Index tracked
Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Mirae Asset Global Investments Co., Ltd.
ISIN
KR7476690003
The investment trusts constructs an index of listed companies in developed countries that generate revenue or conduct R&D related to obesity treatments, with the top two holdings by market capitalization representing 25% each and the remaining eight holdings weighted by market capitalization

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of July 31, 2025
Exposure type
Stocks
Health Technology
Stocks100.09%
Health Technology100.00%
Bonds, Cash & Other−0.09%
Cash−0.09%
Stock breakdown by region
53%43%2%
North America53.90%
Europe43.17%
Asia2.92%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


476690 top holdings are Eli Lilly and Company and Novo Nordisk A/S Sponsored ADR Class B, occupying 26.58% and 17.53% of the portfolio correspondingly.
476690 last dividends amounted to 12.00 KRW. The year before, the issuer paid 15.00 KRW in dividends, which shows a 25.00% decrease.
476690 assets under management is ‪54.95 B‬ KRW. It's fallen 7.90% over the last month.
476690 fund flows account for ‪−84.53 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, 476690 pays dividends to its holders with the dividend yield of 1.74%. The last dividend (Aug 4, 2025) amounted to 12.00 KRW. The dividends are paid annually.
476690 shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Tiger ETF. The ETF was launched on Feb 29, 2024, and its management style is Passive.
476690 expense ratio is 0.45% meaning you'd have to pay 0.45% of your investment to help manage the fund.
476690 follows the Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
476690 invests in stocks.
476690 price has fallen by −5.69% over the last month, and its yearly performance shows a −26.59% decrease. See more dynamics on 476690 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.72% over the last month, showed a −9.84% decrease in three-month performance and has decreased by −13.22% in a year.